Information:
Fel:
ID
34593
Beskrivning
Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02222350
Länk
https://clinicaltrials.gov/show/NCT02222350
Nyckelord
Versioner (1)
- 2019-01-19 2019-01-19 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
19 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes Mellitus NCT02222350
Eligibility Type 2 Diabetes Mellitus NCT02222350
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT02222350
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients aged ≥ 20 years at the time of informed consent
boolean
ID.2
Item
japanese patients with type 2 diabetes
boolean
ID.3
Item
patients who have hba1c ≥ 7.0% and < 10.0% if untreated with antidiabetic agent.
boolean
ID.4
Item
patients who have hba1c ≥ 6.5% and < 9.5% if treated with antidiabetic agent.
boolean
ID.5
Item
patients aged ≥ 70 years at the time of informed consent
boolean
ID.6
Item
patients with a history of type 1 diabetes or diabetic ketoacidosis
boolean
ID.7
Item
patients receiving or requiring treatment with insulin
boolean
ID.8
Item
patients with a body mass index (bmi) of < 18.5 kg/m2 or ≥ 35.0 kg/m2
boolean
ID.9
Item
patients with an estimated glomerular filtration rate (egfr), < 45 ml/min per 1.73 m2
boolean
ID.10
Item
patients with fasting plasma glucose ≥ 240 mg/dl
boolean